{
    "Trade/Device Name(s)": [
        "Invader\u00ae UGT1A1 Molecular Assay",
        "UGT1A1 Molecular Assay"
    ],
    "Submitter Information": "Third Wave Technologies, Inc.",
    "510(k) Number": "K051824",
    "Predicate Device Reference 510(k) Number(s)": [
        "K043576"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NTI"
    ],
    "Summary Letter Date": "August 11, 2005",
    "Summary Letter Received Date": "August 15, 2005",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.3360"
    ],
    "Regulation Name(s)": [
        "Drug metabolizing enzyme genotyping system"
    ],
    "Analyte Class(es)": [
        "genetic molecular",
        "tdm"
    ],
    "Analyte(s)": [
        "UGT1A1 gene",
        "TA6 allele",
        "TA7 allele"
    ],
    "Specimen Type(s)": [
        "Whole peripheral blood",
        "Genomic DNA"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Microtiter plate reader"
    ],
    "Method(s)/Technology(ies)": [
        "Invader\u00ae DNA probe chemistry",
        "Structure-specific cleavage enzyme",
        "Fluorescent resonance energy transfer (FRET)",
        "Interpretative software"
    ],
    "Methodologies": [
        "Genotyping",
        "Nucleic acid probe hybridization",
        "Signal amplification"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit",
        "Software"
    ],
    "Document Summary": "FDA 510(k) summary for Invader\u00ae UGT1A1 Molecular Assay for genotyping UGT1A1 alleles in genomic DNA from whole blood to assess risk for decreased UDP-glucuronosyltransferase activity",
    "Indications for Use Summary": "In vitro diagnostic test for detection and genotyping of *1 (TA6) and *28 (TA7) alleles of the UGT1A1 gene in genomic DNA from whole peripheral blood as an aid in identifying patients with increased risk for decreased UDP-glucuronosyltransferase activity",
    "fda_folder": "Toxicology"
}